BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9226106)

  • 1. Current concepts and advances in clinical laboratory testing for autoimmune diseases.
    Hang LM; Nakamura RM
    Crit Rev Clin Lab Sci; 1997; 34(3):275-311. PubMed ID: 9226106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of elevated antinuclear antibody test in patients with Hodgkin's and Non-Hodgkin's lymphoma: a single center experience.
    Altintas A; Cil T; Pasa S; Danis R; Kilinc I; Ayyildiz O; Muftuoglu E
    Minerva Med; 2008 Feb; 99(1):7-14. PubMed ID: 18299692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases.
    Tektonidou MG; Anapliotou M; Vlachoyiannopoulos P; Moutsopoulos HM
    Ann Rheum Dis; 2004 Sep; 63(9):1159-61. PubMed ID: 15308528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
    Gulez N; Karaca NE; Aksu G; Kutukculer N
    Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.
    Hanly JG; Thompson K; McCurdy G; Fougere L; Theriault C; Wilton K
    J Immunol Methods; 2010 Jan; 352(1-2):147-52. PubMed ID: 19836394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic.
    Vlachoyiannopoulos PG; Tzavara V; Dafni U; Spanos E; Moutsopoulos HM
    J Rheumatol; 1998 May; 25(5):886-91. PubMed ID: 9598885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
    Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of multiplexed bead-based immunoassays for detection of autoantibodies to nuclear antigens.
    Avaniss-Aghajani E; Berzon S; Sarkissian A
    Clin Vaccine Immunol; 2007 May; 14(5):505-9. PubMed ID: 17376860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
    Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
    Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
    Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
    Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of non-organ specific autoantibodies. Their relevance for the differentiation of autoimmune diseases].
    Blaschek MA
    Wien Med Wochenschr; 1987 Jul; 137(13):295-301. PubMed ID: 3307167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results.
    Bonaguri C; Melegari A; Ballabio A; Parmeggiani M; Russo A; Battistelli L; Aloe R; Trenti T; Lippi G
    Autoimmun Rev; 2011 Nov; 11(1):1-5. PubMed ID: 21741498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
    Ramos-Casals M; Brito-Zerón P; Font J
    Semin Arthritis Rheum; 2007 Feb; 36(4):246-55. PubMed ID: 16996579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.